EQS-News
Gerresheimer partners with RxCap to offer connected adherence solutions - Seite 2
Minority shareholding and seat on the Board of Directors
As part of the partnership, Gerresheimer has acquired a minority stake in RxCap in addition to the exclusive distribution rights for pharmacies in the United States. Gerresheimer will also appoint a representative to RxCap's Board of Directors.
Remote Therapeutic Monitoring
Patient adherence to medication is crucial for therapy outcome and can prevent cost-intensive hospitalizations. Digital therapy support is becoming increasingly important in this area, not only through body-worn sensors and apps, but also through connected primary packaging and delivery systems and medication adherence monitoring.
Under the partnership agreement Centor will offer RxCap’s suite of connected prescription vial closure devices and complementary cloud-based software to pharmacies to help them monitor their patients’ prescription adherence. These solutions require no additional effort from the patient and can easily be integrated with existing enterprise workflows to manage patient needs effectively.
Using a cellular signal, the RxCap reports to the cloud-based software platform when the prescription vial has been opened. Pharmacy staff can easily and quickly assess whether the medication has been taken as prescribed and remind the patient to take the medication by text message or phone call.
This partnership will enable pharmacies to quickly launch adherence solutions that can support patient’s health journey more effectively, with minimal additional investments in their workflow, and create new revenue streams.
Lesen Sie auch
RxCap now available for U.S. pharmacies
The RxCap solution is now available for U.S. pharmacies and can be ordered directly from Centor. Centor is thus expanding its product offering in the U.S., positioning itself in the market for remote therapeutic monitoring and also benefiting from recurring revenues while making significant impact on patient health outcomes.
For order inquiries and questions, pharmacies can contact Centor at prescription@centorrx.com.
About RxCap
RxCap, Inc. is a Boston-based prescription adherence technology corporation enabling better patient outcomes and reducing health care costs. The company supports healthcare enterprises in
developing customized remote therapeutic monitoring programs with a modular suite of enablement software, APIs, and prescription adherence devices. By partnering with RxCap, enterprises can quickly
build revenue-generating RPM programs that integrate with their existing care workflows.